Myrobalan Therapeutics, a biotechnology company developing potent, selective, and brain-penetrant oral small-molecule therapies to restore brain function, today announced a grant of over $850,000 from ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback